Valuation: Lunit Inc.

Market Cap 1,173B 879M 798M 737M 665M 1.26B 82.12B 1.3B 8.88B 3.51B 44.31B 3.3B 3.23B 140B P/E 2026 *
-13.6x
P/E 2027 * -23.6x
Enterprise Value 1.07B 805K 730K 675K 609K 1.15M 75.18M 1.19M 8.13M 3.22M 40.57M 3.02M 2.96M 128M EV / Sales 2026 *
11.5x
EV / Sales 2027 * 10.7x
Free-Float
85.69%
Yield 2026 *
-
Yield 2027 * -
11-12 Lunit Inc. announced that it has received KRW 47.7 billion in funding from BNK Securities Co.,Ltd., Yuanta Securities Korea Co., Ltd. CI
11-12 Lunit Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026 CI
11-09 Lunit Announces Supply Of AI-Powered Imaging Solutions To Saudi Arabia's Ministry Of National Guard Health Affairs And Solutions By STC CI
11-06 SK Biopharmaceuticals Joins Consortium for AI Specialized Foundation Model Project MT
11-04 Lunit Announces Presentation Of AI-Powered Pathology Platform Lunit SCOPE At SITC 2026 CI
11-04 Lunit Inc. announced that it expects to receive KRW 47.7 billion in funding from BNK Securities Co.,Ltd., Yuanta Securities Korea Co., Ltd. CI
10-23 Summit Therapeutics Inc. And Lunit Inc. Announce Agreement To Apply AI-Powered SCOPE IO Platform For Tumor Microenvironment Analysis In Immuno-Oncology Development CI
10-14 Lunit Announces Nature Medicine Study Findings on Lunit Scope Identifying Her2 Expression Differences Linked to Treatment Response CI
10-13 Lunit and Discovery Life Sciences Collaborate To Expand AI-Powered Tissue Analysis For Biopharma Research CI
09-28 Lunit Expands Lunit Insight MMG as an Independent Second Reader Across the Entire Stockholm Region in Sweden CI
09-10 Lunit Announces Collaboration with 10x Genomics to Integrate AI-Enabled Pathology Analysis with Spatial Molecular Data for Oncology Clinical Research CI
09-10 10x Genomics to Integrate Lunit's AI-Powered Pathology Platform Into Workflow MT
09-08 Lunit Unveils New AI-Powered Tumor Microenvironment Insights In Lung Cancer At WCLC 2026 CI
1 day-0.38%
1 week-6.41%
Current month+0.45%
1 month+33.11%
3 months+49.24%
6 months-13.83%
Current year-23.31%
1 week 12,340
Extreme 12340
16,300
1 month 10,700
Extreme 10700
17,570
Current year 8,180
Extreme 8180
24,900
1 year 8,180
Extreme 8180
24,900
3 years 8,180
Extreme 8180
50,250
5 years 4,725
Extreme 4725
69,875
10 years 4,725
Extreme 4725
69,875
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer 41 23/08/2013
Chief Executive Officer 43 01/01/2016
Corporate Officer/Principal 40 -
Director TitleAgeSince
Chairman 43 -
Director/Board Member 43 01/01/2016
Director/Board Member 50 30/03/2022
Date Insider Type Main position Quantity % Market Cap. Importance
4/12/26 A Others

Founder

132,154 0.3553%
4/12/26 A Sell 31,562 0.0849%
4/12/26 A Sell

Chief Technology Officer

137,454 0.3696%
Change 5-day change 1-year change 3-year change Capi.($)
-0.38%-6.41%-18.02%-66.57% 882M
-0.11%-4.17%+19.40%+46.64% 254B
+0.34%-3.63%+0.56%+7.46% 159B
-1.12%-5.05%-21.94%+37.09% 149B
+1.42%-4.41%-56.52%-20.79% 62.37B
-0.06%-0.32%+25.50%+56.97% 60.62B
+1.28%+0.34%+5.05%-12.66% 53.05B
+1.15%-1.51%+21.16%+52.90% 48.55B
-2.09%-6.49%+4.12%+59.48% 46.7B
+2.11%-2.47%+21.95%+76.02% 44.21B
Average +0.26%-0.64%+0.13%+23.65% 88B
Weighted average by Cap. +0.08%-2.98%+2.52%+32.68%

Financials

2026 *2027 *
Net sales 93.08B 69.72M 63.29M 58.46M 52.74M 99.57M 6.51B 103M 704M 279M 3.51B 262M 256M 11.11B 104B 77.91M 70.72M 65.33M 58.94M 111M 7.28B 116M 787M 311M 3.93B 292M 286M 12.41B
Net income -87.06B -65.21M -59.2M -54.68M -49.33M -93.13M -6.09B -96.7M -659M -261M -3.29B -245M -240M -10.39B -49.24B -36.88M -33.48M -30.93M -27.9M -52.68M -3.45B -54.69M -373M -147M -1.86B -138M -135M -5.88B
Net Debt -99.24B -74.33M -67.48M -62.33M -56.23M -106M -6.94B -110M -751M -297M -3.75B -279M -273M -11.84B -55.66B -41.69M -37.84M -34.96M -31.54M -59.54M -3.89B -61.82M -421M -167M -2.1B -156M -153M -6.64B
Projected Income Statement - Annual - Lunit Inc.
Logo Lunit Inc.
Lunit Inc is a Korea-based company principally engaged in the development and supply of medical software. The Company is principally engaged in the development and supply of medical software such as cancer diagnostic aid solutions, cancer early detection solutions, cancer risk prediction solutions and others through artificial intelligence (AI) technologies.
Employees
1,330
Date Price Change Volume
18/11/26 ₩15,760.00 -0.38% 1,428,417
17/11/26 ₩15,820.00 +7.62% 2,665,851
16/11/26 ₩14,700.00 -2.13% 1,438,165
13/11/26 ₩15,020.00 +9.48% 3,887,309
12/11/26 ₩13,720.00 -2.97% 3,838,115
Trader
Investor
-
Global
-
Quality
ESG MSCI
AA
MarketScreener Ratings - Lunit Inc.
Sell
Consensus
Buy
Mean consensus
SELL
Number of Analysts
1
Last Close Price
15,820.00KRW
Average target price
12,150.00KRW
Spread / Average Target
-23.20%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Lunit Inc.
  1. Stock Market
  2. Stocks
  3. A328130 Stock